脑部放疗，上午比下午敏感许多！
) r$ K' x# i" X9 M) X/ T, M
: ^. m8 \; `7 [: }- g- I
G* l7 n$ r$ Y3 t6 } tCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
$ z9 D- f6 E' s6 X) Q$ V* W Q YGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
/ m$ W7 M+ L* \1 ORahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
4 m& B( Q/ L* r6 R3 v1 q8 iSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.0 b! B* y% B+ ]* O! m8 J3 |
: q0 B" r# z3 P, M' ]. ~
Abstract
! j0 B. E4 h- B( {/ OBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
; l# R. S% ?2 ^& n# O1 m. l2 s5 n# M" t* u+ M( g
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.8 r! l, u4 l! t6 l- F; x
2 F8 P3 m8 z2 ]( P: M( s$ v
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
+ J0 X; l5 Z: W" u$ \. x4 l' E. C3 g) |4 O# h9 m
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
6 ^& d& f E9 O7 s/ L5 r/ B
- H/ ]0 [9 F3 k |
/ N) i- l* W9 m: Y4 z# ~' Y
显身卡
